Sclerostin Quo Vadis? - Is This a Useful Long-Term Mortality Parameter in Prevalent Hemodialysis Patients?

• Main Authors: Albina Nowak (Author), Ferruh Artunc (Author), Andreas L. Serra (Author), Emily Pollock (Author), Pierre-Alexandre Krayenbühl (Author), Christian Müller (Author), Björn Friedrich (Author)
• Formato: Livro
• Publicado em: Karger Publishers, 2015-05-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background/Aims: Cardiovascular calcification contributes to the increased mortality in hemodialysis patients. Sclerostin was identified as an antianabolic bone factor causing soft tissue calcification. Data on prospective large-scale studies associating sclerostin with mortality in hemodialysis pat...